Redmile as of Sept. 30, 2015
Portfolio Holdings for Redmile
Redmile holds 58 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 21.5 | $1.0B | 1.1M | 898.75 | |
| Sage Therapeutics (SAGE) | 13.2 | $626M | 1.1M | 547.77 | |
| Seattle Genetics | 9.9 | $470M | 1.4M | 337.86 | |
| Neuroderm Ltd F | 8.9 | $424M | 1.5M | 289.86 | |
| Portola Pharmaceuticals | 8.3 | $392M | 770k | 509.33 | |
| Oxford Immunotec Global | 6.3 | $299M | 1.0M | 290.67 | |
| Zs Pharma | 5.5 | $259M | 514k | 502.79 | |
| Rite Aid Corporation | 4.7 | $224M | 8.1M | 27.72 | |
| Amicus Therapeutics (FOLD) | 2.5 | $117M | 8.3M | 13.99 | |
| Clovis Oncology | 1.9 | $88M | 958k | 91.96 | |
| WellCare Health Plans | 1.7 | $82M | 514k | 158.72 | |
| Array BioPharma | 1.7 | $81M | 18M | 4.56 | |
| Medivation | 1.6 | $75M | 1.8M | 42.50 | |
| Incyte Corporation (INCY) | 1.4 | $68M | 614k | 110.33 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $53M | 1.3M | 40.04 | |
| Penumbra (PEN) | 1.1 | $51M | 1.6M | 32.64 | |
| Chimerix (CMRX) | 0.9 | $41M | 1.1M | 38.20 | |
| Centene Corporation (CNC) | 0.8 | $41M | 748k | 54.23 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $39M | 369k | 105.32 | |
| Atara Biotherapeutics (ATRA) | 0.7 | $33M | 1.0M | 31.44 | |
| Nanostring Technologies (NSTGQ) | 0.5 | $22M | 1.4M | 16.00 | |
| Celldex Therapeutics | 0.4 | $21M | 2.0M | 10.54 | |
| Dbv Technologies S A (DBVT) | 0.4 | $19M | 533k | 35.59 | |
| Insmed (INSM) | 0.4 | $18M | 948k | 18.57 | |
| Dynavax Technologies (DVAX) | 0.4 | $18M | 724k | 24.54 | |
| Model N (MODN) | 0.3 | $14M | 1.4M | 10.01 | |
| Conformis | 0.3 | $12M | 689k | 18.06 | |
| Health Net | 0.2 | $11M | 179k | 60.22 | |
| Fate Therapeutics (FATE) | 0.2 | $11M | 2.1M | 5.33 | |
| Trinet (TNET) | 0.2 | $11M | 639k | 16.80 | |
| Global Blood Therapeutics In | 0.2 | $11M | 263k | 42.16 | |
| Oncothyreon | 0.2 | $9.9M | 3.6M | 2.74 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $9.6M | 661k | 14.57 | |
| Blueprint Medicines (BPMC) | 0.2 | $7.8M | 368k | 21.34 | |
| Cerus Corporation (CERS) | 0.1 | $7.3M | 1.6M | 4.54 | |
| Aquinox Pharmaceuticals | 0.1 | $7.2M | 514k | 14.07 | |
| Trivascular Technologies | 0.1 | $7.3M | 1.5M | 5.00 | |
| Avalanche Biotechnologies In | 0.1 | $6.2M | 748k | 8.24 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $6.1M | 277k | 22.03 | |
| DURECT Corporation | 0.1 | $5.1M | 2.6M | 1.95 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $5.0M | 590k | 8.45 | |
| Invitae (NVTAQ) | 0.1 | $4.8M | 660k | 7.22 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.1 | $4.0M | 4.0M | 0.99 | |
| Chemocentryx | 0.1 | $3.0M | 501k | 6.05 | |
| Castlight Health | 0.1 | $3.1M | 734k | 4.20 | |
| Press Ganey Holdings | 0.1 | $2.5M | 85k | 29.59 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $2.0M | 191k | 10.42 | |
| Eleven Biotherapeutics | 0.0 | $2.0M | 848k | 2.41 | |
| Nevro (NVRO) | 0.0 | $1.2M | 25k | 46.40 | |
| SPDR S&P Biotech (XBI) | 0.0 | $576k | 9.3k | 62.27 | |
| Market Vectors Etf Tr pharmaceutical | 0.0 | $409k | 6.5k | 62.92 | |
| Genocea Biosciences | 0.0 | $628k | 92k | 6.85 | |
| Aduro Biotech | 0.0 | $311k | 16k | 19.37 | |
| Pronai Therapeutics | 0.0 | $377k | 18k | 20.50 | |
| Cerner Corporation | 0.0 | $214k | 3.6k | 60.06 | |
| NxStage Medical | 0.0 | $186k | 12k | 15.76 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $199k | 25k | 8.10 | |
| Jazz Pharmaceuticals (JAZZ) | 0.0 | $235k | 1.8k | 132.84 |
